2.2 Diagnostic & Laboratory Testing in IPC

2.2 Diagnostic & Laboratory Testing in IPC

The diagnostic microbiology laboratory acts as the essential intelligence center for an Infection Prevention and Control (IPC) program. Timely, accurate laboratory identification of pathogens, resistance mechanisms, and epidemiological markers empowers Infection Preventionists (IPs) to implement transmission-based precautions, detect clinical outbreaks, and collaborate effectively with clinical care teams and antimicrobial stewardship programs.

---

Specimen Management & Pre-Analytical Quality

The diagnostic accuracy of laboratory testing is inextricably linked to pre-analytical quality. Contaminated or inappropriately collected specimens lead to false-positive diagnoses, unnecessary broad-spectrum antimicrobial usage, and erroneous HAI reporting.

Key Pre-Analytical Rules

1. Collect Prior to Antimicrobial Initiation: Specimen collection must occur before starting empirical antimicrobial therapy whenever clinically feasible to maximize pathogen recovery.
2. Aseptic Technique & Contamination Control: Blood cultures require stringent skin antisepsis (e.g., 2% chlorhexidine in 70% isopropyl alcohol) allowed to dry completely. Facilities must maintain blood culture contamination rates below the standard benchmark of <3.0% (with leading institutions achieving <1.0%).
3. Proper Anatomical Collection: Collect active inflammatory exudate from deep wound margins rather than superficial swabbing of open chronic ulcers or drain sites.
4. Timely Transport & Preservation: Transport specimens promptly within designated timeframes utilizing appropriate transport media (e.g., Cary-Blair for stool, Amies/Stuart for swabs) under correct temperature conditions to prevent overgrowth of fastidious commensal flora.

---

Microscopic Examination & Staining Techniques

Microscopic examination provides immediate preliminary information long before culture results become available.

Gram Stain Principles

Developed by Hans Christian Gram, this differential staining method classifies bacteria into two broad groups based on cell wall composition:

• Gram-Positive Bacteria: Retain the primary dye (crystal violet) and appear purple/blue under light microscopy. Their thick peptidoglycan cell wall retains the crystal violet-iodine complex even after decolorization with alcohol or acetone.
• Gram-Negative Bacteria: Lose crystal violet during alcohol decolorization due to a thin peptidoglycan layer and high lipid content in their outer membrane. They absorb the counterstain (safranin or basic fuchsin) and appear pink/red.

[Gram-Positive]  Cell Wall: Thick Peptidoglycan --------> Retains Crystal Violet (PURPLE)
[Gram-Negative]  Cell Wall: Thin Peptidoglycan + LPS ----> Retains Safranin Counterstain (PINK/RED)

Specialized Stains

• Acid-Fast Stain (Ziehl-Neelsen / Kinyoun): Used for organisms with cell walls rich in mycolic acids (waxy lipids) that resist standard Gram staining. Mycobacterium tuberculosis and Non-Tuberculous Mycobacteria (NTM) stain bright pink/red against a blue background.
• Fungal Stains: Calcofluor White (fluorescent stain binding to chitin in fungal cell walls) and India Ink (negative stain highlighting the polysaccharide capsule of Cryptococcus neoformans).

---

Culture Media & Phenotypic Identification

Culture remains fundamental for isolating viable microorganisms for subsequent susceptibility testing and strain typing.

Types of Culture Media

• Enriched Media: Contain complex nutrients (e.g., Blood Agar, Chocolate Agar) supporting the growth of fastidious organisms such as Streptococcus pneumoniae and Haemophilus influenzae.
• Selective Media: Incorporate chemical agents that suppress unwanted background flora while permitting target pathogens to grow (e.g., MacConkey Agar contains bile salts and crystal violet to inhibit Gram-positive organisms, selecting exclusively for Gram-negative rods).
• Differential Media: Contain indicators (e.g., pH dyes or carbohydrates) that visually differentiate organisms based on metabolic properties. On MacConkey Agar, lactose fermenters (e.g., Escherichia coli, Klebsiella pneumoniae) produce bright pink colonies, whereas non-lactose fermenters (e.g., Pseudomonas aeruginosa, Salmonella spp.) produce colorless colonies.

Key Biochemical Identification Tests

---

Advanced Identification: MALDI-TOF Mass Spectrometry

Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometry has revolutionized clinical microbiology. By analyzing the unique ribosomal protein spectrum of an isolated bacterial or fungal colony, MALDI-TOF matches protein mass profiles against an extensive reference database, providing definitive species identification within minutes rather than days.

---

Molecular Diagnostics & Strain Typing

Molecular technologies detect pathogen nucleic acids (DNA/RNA) directly from clinical specimens, offering unmatched sensitivity and rapid turnaround times.

Nucleic Acid Amplification Tests (NAAT / PCR)

• Multiplex Real-Time PCR: Simultaneously amplifies multiple target genes in a single reaction (e.g., respiratory virus panels, GI pathogen panels, blood culture identification panels).
• Diagnostic Caveat for IPs: PCR assays detect target nucleic acid sequences regardless of organism viability. A positive PCR result after successful treatment may reflect harmless shedding of non-viable genetic fragments rather than active infection.

Molecular Typing Methods for Outbreak Investigations

When investigating suspected healthcare-associated clusters, IPs rely on molecular typing to establish genetic clonality among isolated pathogens.

---

Antimicrobial Susceptibility Testing (AST) & MIC

AST measures the in vitro activity of antimicrobial agents against isolated bacterial pathogens, guiding clinical therapy and epidemiologic tracking of drug resistance.

Minimum Inhibitory Concentration (MIC)

The MIC is the lowest concentration of an antimicrobial agent that completely inhibits visible in vitro growth of a microorganism. Clinical and Laboratory Standards Institute (CLSI) and EUCAST establish standard breakpoints to classify MIC results into interpretive categories:

• Susceptible (S): Organism is inhibited by reachable systemic drug concentrations using standard dosing schedules.
• Intermediate (I): Efficacy may occur in body sites where drugs concentrate, or when higher doses are administered.
• Resistant (R): Organism is not inhibited by achievable systemic concentrations of the agent.

Facility Antibiograms

An antibiogram is an annual aggregate report of cumulative antimicrobial susceptibility profiles of common clinical isolates within a healthcare facility. IPs use antibiograms to monitor longitudinal resistance trends, detect emerging multidrug-resistant organisms (MDROs), and inform empirical treatment guidelines.

---

Biosafety Levels (BSL-1 to BSL-4)

Laboratory safety containment levels are structured based on pathogen infectivity, severity of disease, transmission route, and availability of treatments.

• BSL-1: Well-characterized agents not known to consistently cause disease in immunocompetent adult humans (e.g., non-pathogenic E. coli). Standard microbiological practices.
• BSL-2: Agents that pose moderate hazards to personnel and the environment (e.g., MRSA, HBV, HIV, Salmonella). Requires restricted access, biohazard signage, and Biosafety Cabinets (BSCs) for aerosol-generating procedures.
• BSL-3: Indigenous or exotic agents with potential for airborne transmission that may cause serious or lethal infection (e.g., Mycobacterium tuberculosis, Brucella spp., SARS-CoV-2, Francisella tularensis). Requires negative air pressure, directional airflow, HEPA filtration, and controlled access.
• BSL-4: Dangerous and exotic agents posing high individual and community risk of life-threatening disease with no available vaccine or treatment (e.g., Ebola virus, Marburg virus, Smallpox). Requires full-body positive-pressure suit, dedicated air supply, and maximum containment facility controls.